Some Fundamentals Of Gonadal Development And Function by Smith, Richmond W., Jr. & Mellinger, Raymond C.
Henry Ford Hospital Medical Journal
Volume 8 | Number 3 Article 8
9-1960
Some Fundamentals Of Gonadal Development
And Function
Richmond W. Smith Jr.
Raymond C. Mellinger
Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal
Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health
Commons
This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry
Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. For more information, please contact
acabrer4@hfhs.org.
Recommended Citation
Smith, Richmond W. Jr. and Mellinger, Raymond C. (1960) "Some Fundamentals Of Gonadal Development And Function," Henry
Ford Hospital Medical Bulletin : Vol. 8 : No. 3 , 324-344.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol8/iss3/8
SOME FUNDAMENTALS OF GONADAL DEVELOPMENT 
AND FUNCTION* 
RICHMOND W . SMITH, JR., M.D.** AND RAYMOND C. MELLINGER, M.D.** 
The traditional division of animal life into male and female forms is based 
on obvious biological differences, but these distinctions become less striking when 
we realize that life, in a sheer physico-chemical sense, is a spectrum of sexuality 
that maleness and femaleness are relative terms. Our conceptual devotion to a 
two compartment universe is apparent in many areas of life, sociologic, moral, legal, 
spiritual or biologic. Although reproductive obligations remain clear, albeit increasingly 
restricted, man's greater social sophistication is molding an order in which underlying 
biological distinctions of the two sexes are sometimes obscured by the potent solvents 
of culture, leisure and intellect. The purpose of this essay is to review some fundamental 
aspects of gonadal development and function, presenting similarities as well as 
differences between the male and female forms. Since few areas of biology have 
been favored with such significant contributions as have come recently to the 
fields of genetics and embryology, it is logical to begin with a brief review of these 
before discussing the prevailing concepts of gonad endocrinology. 
The classical concept that the germinal epithelium of the vertebrate gonad has 
its origin in the primitive coelomic epithelium has been challenged by the Weismann' 
viewpoint which has received support in the studies of Fuss^ Witschi' and McKay 
et al.'' It proposes that the primordial germ cells, arising de novo in the yolk sac 
endoderm, migrate through the mesenchyme to their final destination and become the 
fetal gonad. As shown in Figure 1 the hormone-producing structures of ovary, testis 
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Figure 1 
Embryologic derivation of adrenal and gonadal tissue. 
and adrenal are derived from one select area of the mesoderm which might be labeled 
the steroid-gland primordium. The gonadal ridges are apparent in the human embryo 
at about the fourth week of fetal development, and until the seventh week the 
gonads of the genetic male and female embryos are indistinguishable (see Fig. 2) . 
Fusing of the bipotential primordial germ cells with the hormonal cells of mesodermal 
origin results in the embryonic gonad, consisting of the primary sex cords surrounded 
*Presented in part at the Eighth Annual Graduate Symposium on the Dynamics of Endocrine and 
Metabolic Disease sponsored by Highland-Alameda County Hospital, Oakland, California, Feb 1960 
** Division of Endocrinology. 
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Figure 2 
Embryologic development of the human gonad. Male and female structures are indistinguishable 
until after the 7th week (from Barr.s by permission of the author). 
by the cortex. At this critical junction the fate of the indifferent gonad is decided 
by subtle forces which have been termed "inductors". As stated by Barr,' germ 
cells assume the male or female sex character not because of their respective genie 
make-up but in response to inductive stimuli. Simultaneously, gonia begin differentia-
tion along spermatogenetic hnes if originally located in the medulla, or along ovogenetic 
lines if the primordial germ cells reside in the gonadal cortex. At about the seventh 
week in embryos of XY chromosomal complex, the medulla begins to develop and 
the cortex to regress while the sex cords, differentiating to early seminiferous tubules, 
are interspersed with interstitial cells. The gonadal cortex in male embryos develops 
ultimately into the thin, visceral layer of the tunica albuginea. At the eighth or 
ninth week of embryos with X X chromosomal pattern, the gonadal cortex is invaded 
by sex cords, the medulla regresses and the gonad develops into an ovary. Disruption 
of the critical differentiation in the bipotential gonad at this point may result in sex 
anomalies. Such interference may be the result of a mutant gene, a defective 
chromosome carrying sex determiners, or a nongenetic factor such as a chemical 
or hormone, either of endogenous or exogenous origin. 
Experimental grafting of embryonic rat ovary and testis into castrated adult 
hosts results in suppression of the differentiation of the embryonic ovary while the 
testis remains unaffected.'-' Holyoke and Beber= augmenting these experiments, made 
tissue cultures of the paired embryonic gonads from both rabbit and rat. The 
embryonic testes grew well in all combinations, whereas development of ovaries 
cultured with young testes was markedly retarded (Table I . ) . In some instances 
masculinizing effects occurred as shown by the presence in ovaries of testicular 
cords in the medullary portions. It was deduced that the embryonic testis produces 
a substance capable of altering the embryonic ovary. That this substance is a 
hormone distinct from adult male hormone is concluded from the observation that 
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Table I 
Effects of Hormonal Environment on the Development of the Mammalian Ovary 
(rat and rabbit embryos)* 
Host Hormonal Environment Ovary Development 
Castrate adult male O normal 
Intact adult male male hormone normal 
Intact adult male testis normal 
Castrate adult male embryonic ovary normal 
Castrate adult male embryonic testis retarded 
Organ culture embryonic ovary normal 
Organ culture embryonic testis retarded 
*based on report of Holyoke and Beber.8 
the same embryonic ovary can 
grafted to the host testis. 
The secondary sex structures, 
begins, also have a developmental 
develop normally in an adult male even when 
already in existence when gonadal differentiation 
bipotential (Fig. 3). The ovaries are apparently 
indifferent gonad 
Wolffian duct 
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urogenital sinus 
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Figure 3 
Development of the sex ducts in normal and gonadectomized rabbit embryos (from Jost,' by courtesy 
Cambridge University Press). 
not essential for continuing differentiation and growth of the Miillerian system but 
the embryonic testis, through a presumed hormonal inductor, is critical for Wolffian 
duct maturation. Barr' has stated "the requirement of a masculine evocator of 
testicular origin to counteract a tendency of all embryos to feminize is a keystone 
in current concepts of the pathogenesis of congenital errors of sex development". The 
inherent feminizing propensity of embryos seems genetically regulated and not the 
result of maternal estrogen or some exogenous factor. The genes involved must 
I 
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not be those for the male and female determiners of gonadal differentiation since 
female duct development can occur even in the absence of a normal X X sex chromo-
some complex and a maturing ovary. Finally, from recent studies of patients with 
sexual anomalies it appears that the Y chromosome is not genetically passive but carries 
potent male-determining genes. 
The development of a histologic test for sex chromatin determination has con-
tributed greatly to the understanding of the mechanisms involved in both normal 
and abnormal sex differentiation. This relatively simple technique, introduced by 
Moore and Barr'" in 1953, makes possible the accurate recognition of chromosomal 
sex, thus providing the critical link between gonadal morphology and phenotype in 
man. The feature which identifies the nuclei of females is a large, dense chromatin 
particle, usually in proximity to the nuclear membrane and found often to be a 
bipartite body. In properly prepared sections of female tissue it can be identified 
in 60 to 70 per cent of the nuclei. Barr= states that the densely staining body 
probably represents the heterochromatic regions of the two X chromosomes. Its 
presence, however, does not necessarily mean a normal X X structure since unusual 
chromosomal complexes have been described for patients with Klinefelter's syndrome 
( X X Y ) " and for the "super-female" individual ( X X X ) " . Conversely, its absence 
Figure 4 
Microscopic (X400) structure of an ovary from a fetus 25 weeks old (ovulation age). Primordial 
germ cells and 'nurse' cells are almost indistinguishable in cortical area (right upper half of 
photograph). Germ cells are better differentiated from 'nurse' cells in lower half of the section 
where the latter are seen surrounding the primordial ova. 
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indicates that two X chromosomes are not present, which could mean either a 
normal XY complex or an abnormal XO structure (Turner's syndrome). 
DIFFERENTIATION A N D MATURATION OF THE OVARY 
In the normal subject with X X chromosome complex, the joining of the germ 
cells and mesenchymal hormonal cells at the locus of the fetal gonad results in 
the maturing ovary. In Figure 4, taken from a publication by Garcia and Rock,'^ 
are shown the primitive elements in an ovary of a 25 week old fetus. The mesenchymal 
interstitial cells, or "nurse" cells, are the precursors of the granulosa cells which 
eventually surround each primordial ova. By the time of birth neariy all germ 
cells have been so surrounded. The actual number of primordial follicles existing 
at birth appears to vary widely but approximates 200,000 per ovary. Only a small 
fraction show any signs of further maturity. The weight of evidence favors the 
idea that aging of the ovary begins at birth and no new primordial ova are formed, 
the attrition through ova-death or ovulation progressively depleting the gonad. By 
age 40 to 50 only a few thousand primordial follicles can be found. A progressive 
thinning of the cortex ensues, the surface wrinkles and the medulla appears relatively 
conspicuous, having become the repository for multiple corpora albicantia. 
It is generally held that FSH accelerates the growth and maturation of the 
ovarian follicles through its effect on the granulosa cells which, surrounding each 
ovum throughout fetal and juvenile life, have promoted a slow process of follicular 
maturation (Fig. 5). As granulosa cell activity increases, a local stimulus results 
Secondary Oocy te 
G ra nulosa 
Figure 5 
Schematic representation of the micro-anatomy of the ovary, showing follicular maturation and 
structure of the Graafian follicle. 
in the formation of a surrounding theca interna which in turn autonomously elaborates 
estrogen as estradiol. This hormone now becomes the key factor in further gonadal 
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and folhcular growth. It directly affects the amount and composition of the 
follicular fluid, while the follicle expands eccentrically, forming the antrum and the 
Graafian follicle. The FSH-induced increase in estrogen production by the follicle 
provokes the pituitary into releasing the luteinizing hormone which in combination 
with FSH furthers the follicular maturation. The theca interna begins elaborating 
small amounts of progesterone, the follicle becomes distended and the stage is set 
for ovulation. At this point the action of the third tropic substance, luteotropin or 
prolactin, leads to release the ovum. During this time the ovogonium has matured 
through mitotic and reductional division to a secondary oocyte with 23 chromosomes. 
This cell is approximately five to seven times larger than the primordial germ cell, 
excluding the zona pellucida. The exact hormonal chain of events at dehiscence of 
the follicular wall is not known. Luteinization of the ruptured follicle follows, and 
with this proliferation of hormonally active cells, increased amounts of estrogen and 
progesterone are produced. FSH release by the pituitary is suppressed and luteotropin 
dominates ovarian control with emphasis on progesterone formation until the end 
of the luteal phase. 
That this chain of events applies to man is still unproved since gonadotropin 
assays have not been perfected to the degree that luteotropin can be separated with 
confidence from FSH and L H in human urine. Furthermore, the experimental 
induction of ovulation in primates has proved difficult, Knobil et al" only recently 
having reported the achievement in one hypophysectomized Rhesus monkey receiving 
thyroid, primate FSH and human chorionic gonadotropin. The capacity of purified 
FSH alone to induce marked follicular hypertrophy, however, has been amply 
demonstrated both in primate and infra-primate species. In a 1958 report from Sweden, 
Gemzell and associates" claimed that the injection of human pituitary FSH followed 
by chorionic gonadotropin produced polycystic ovaries and ovulation in amenorrheic 
women. 
Progress in the isolation, purification and characterization of pituitary gonado-
tropins, especially from human sources, has been disappointingly limited."" Small 
amounts of highly purified sheep FSH and L H are becoming available, and data 
are accumulating from the comparative assays of these substances with human 
urinary gonadotropins."-" Yet the latter are excretory products and thus may be 
chemical disfigurements of the original pituitary secretion. As long as bioassay in 
animals remains the best assay procedure, varying as it does from laboratory to 
laboratory, and as long as the source and methods of isolation and purification differ 
widely, the identity and functional interrelationships of human gonadotropins will 
not be readily resolved. In Figure 6 are graphed the results obtained in our laboratory 
for the comparative properties in the immature mouse of human gonadotropins 
from urine of postmenopausal women and young men, and of purified follicle-
stimulating hormone from sheep pituitaries. Although no differences in biologic 
response under conditions of this assay could be demonstrated between the human 
urinary gonadotropins, the sheep FSH produced a significantly different response. 
This difference, which has not been explained, may be due to species specificity or 
to the result of metabolic tranformation or alterations produced in preparation of 
the hormone. 
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Figure 6 
Comparative effects of human urinary gonadotropins and sheep pituitary FSH in the immature 
mouse uterine weight assay. The slopes of the dose-response curves are significantly different. 
DIFFERENTIATION A N D MATURATION OF THE TESTIS 
The three main cellular components of the developing testis are the germinal 
epithelium, the Sertoli cells and the interstitial cells of Leydig. In Figure 7 is 
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Figure 7 
Schematic representation of the micro-anatomy of the mature human testis. 
presented in schematic fashion the microscopic differentiation of the major components 
of the adult human testis. The germinal epithelium of the late fetal and infantile 
gonad is well developed, and except for the lack of spermatogenesis, the architecture 
is essentially that of the adult. The seminiferous tubules are solid i.e. lacking a 
central tubular lumen, and the germinal epithelium consists of resting spermatogonia. 
Spermatogenesis begins at age 11 to 18 years and continues well into the 
sixth decade of life or beyond. The chain of events producing the spermatozoa 
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involves both a primary and secondary maturation division. The development of the 
spermatocytes containing 46 diploid chromosomes is believed to occur in response 
to local hormonal stimulation. In man this maturation is dependent upon gonadotropic 
hormones, but in the rat it is known to proceed without FSH. The miotic division 
to secondary spermatocytes with 23 chromosomes also apparently depends on FSH 
action, but whether this is a direct effect or is mediated through the Sertoli cells 
remains to be established. 
The true function of the Sertoli cells in man is unknown, but they appear 
intimately involved in the process of sperm maturation, possibly serving as a nutrient 
source. One school, perhaps dominant, attributes testicular estrogen production to 
the Sertoli cells, while others have reported evidence which assigns this function 
to the interstitial cells. Whatever is produced, be it substance "X" of Howard'" or 
estradiol, the Sertoli cell often shows histologic evidence of secretory activity, and' 
in the dog, Sertoli cell tumors are often highly productive of estrogens. 
The third functional element of the testis, the interstitial cell of Leydig, is 
the major site of hormonal production. Well developed in the embryo, the interstitial 
cells undergo a period of relative dormancy from birth to puberty at which time 
a resurgence of hormonal activity occurs. That this function is controlled by the 
pituitary through the luteinizing hormone (LH) is a universally accepted concept. 
BIOGENESIS OF GONADAL HORMONES 
Among the recent significant developments in endocrinology has been the elu-
cidation of the biosynthetic pathways of the gonadal hormones. It has long been 
held that estradiol is the chief estrogen produced in the ovary, that testosterone is 
the testicular androgen and that estrogens and androgens of lower potency arise in 
the adrenal cortex. There is evidence for estrogen production by the human testis 
but that for androgen synthesis in the human ovary is less conclusive. 
The basic pattern of chemical events in the biosynthesis of both adrenal and 
gonadal steroids (Fig. 8) has been deciphered primarily through studies of patients 
with hyperfunctioning neoplasms of endocrine glands. As depicted by Dorfman,'' 
the chief substrate, acetate, undergoes a series of molecular couplings yielding 
cholesterol. Probably initiated by the action of pituitary tropic hormones on specific 
enzymes, cholesterol undergoes a side-chain hydrolysis and cleavage, with oxidation 
of C20, to become pregnenolone. The next steps, common to the biosynthesis of all 
adrenal and gonadal steroids, are the oxidation of pregnenolone through the action 
of 3)8-01-dehydrogenase to progesterone, and the 17a-hydroxylation of the latter 
compound to 17a-hydroxyprogesterone. The recent report by Landau" that ad-
ministration of large amounts of chorionic gonadotropin to intact males results in 
an increased excretion of pregnanetriol (a urinary metabolite of 17-hydroxyproges-
terone), supports the concept that 17-hydroxyprogesterone is an intermediate in 
testicular steroid biosynthesis. This latter steroid in turn undergoes oxidative removal 
of the side chain at C17 yielding a 19-carbon steroid, A''-androstene-3:17-dione and 
acetic acid. Testosterone results from reduction of the Ci? ketone group to a 17/3-
hydroxyl group. The major urinary metabolites of testosterone are androsterone, 
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Figure 8 
Chemical pathways in the biosynthesis of the adrenal and gonadal steroid hormones, 
as proposed by Dorfman.^' 
epiandrosterone, androstane 3, 17-dione and three etiocholanes: 3, 17-dione, 3a, 
17a-diol and 3a-ol, 17-one. 
As previously mentioned, the interstitial cells of the testis are the locus of 
androgen biosynthesis in the male. That testosterone is actually produced in the 
human testis has been demonstrated in recent years by Lucas and associates'^  who 
isolated the hormone from the spermatic vein. Hollander and co-workers" more 
recently confirmed this observation and found a progressive decrease in concentration 
of the hormone with age. Although no pure androgen has been recovered from the 
ovary, androgenic activity in ovarian extract was demonstrated 20 years ago.'^  
More recently, Johnson" has demonstrated that implanted ovaries in parabiotic male 
castrate rats when stimulated with gonadotropins can maintain the male secondary 
sex characteristics. It is probable that androgens are synthesized in the ovary in a 
manner similar to that described for the testis. Baggett and co-workers'' have 
demonstrated in human ovarian tissue the conversion of C"-labeled testosterone to 
17/3-estradiol. 
That the adrenal cortex secretes androgenic steroids is evident in the sharp 
increase in urinary 17-ketosteroids which occurs in the puberal period. That a 
major portion of these ketosteroids are of adrenal origin is apparent in the marked 
reduction in their excretion which occurs during adrenal-suppressive therapy with 
the glucocorticoids. During early adult years, women excrete approximately 30 
per cent less urinary androgens and 17-ketosteroids than do contemporary males. 
No quantitative change has been observed during the menstrual cycle. Shown in 
Figure 9 are data concerning the widely recognized decline in urinary neutral 
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Figure 9 
Composite of urinary 17-ketosteroid excretion of 147 women, 
normals and osteoporotics, studied by the authors. 
17-ketosteroid excretion which occurs with age. A similar progressive lowering of 
17-ketosteroid excretion ocurs in the aging male. The studies of Pincus and 
associates'" have shown that this decline in ketosteroid excretion for both sexes 
is much greater for the 11-deoxy fraction than for the 11-oxygenated steroids. That 
this is a change in adrenocortical steroidogenesis and not a result of waning ovarian 
secretion is suggested by the fact that bilateral oophorectomy in the pre-menopausal 
female does not significantly reduce the urinary 17-ketosteroid level. It could be 
interpreted as suggesting that the primary function of Cortisol biosynthesis requires 
progressively less pituitary ACTH as the individual ages, resulting in a proportional 
decrease in androgen secretion. In that sense, adrenocortical function in the aged 
is the reverse of that seen in patients with congenital virilizing adrenal hyperplasia 
a syndrome in which deficient Cortisol production permits excessive ACTH release 
and accelerated adrenal androgen formation. 
In the young woman, estradiol biosynthesis probably occurs for the most part 
in the theca interna, possibly in the granulosa cells. When the ovary atrophies at 
menopause, however, these structures are replaced by functionless corpora albicantia, 
and the interstitial stroma remains as the only potential source of gonadal estrogens. 
That the adrenal cortex contributes estrogen is beyond question, but the extent and 
biological significance of this secretion (probably estrone) are not entirely known. 
The three major estrogens are 17;8-estradiol, estrone and estriol (Fig. 10). 
17^-Estradiol is considered the parent compound, while estrone and estriol are its 
metabolic derivatives. Experimental evidence indicates that estriol can not be con-
verted to estrone or estradiol, although interconversion between estradiol and estrone 
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Chemical relationship of the three major estrogens. 
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Figure 11 
Urinary estrogen levels during the menstrual cycle (adapted from Brown^'). 
is possible. In urine estriol constitutes from 50 to 70 per cent, estrone 20 to 40 
per cent and estradiol 12 to 15 per cent of the total estrogens, expressed in micrograms 
per day. The excretion values for these three substances during typical menstrual 
cycles are shown in Figure 11, data for which have been taken from the studies 
of Brown." 
With advancing years women excrete progressively smaller amounts of all estrogens, 
with a fairly rapid drop occurring iti the fourth decade. The greatest reduction occurs 
in the estriol fraction. This change; is shown in Figure 12, representing data from 
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Figure 12 
Urinary excretion of estrogens by men and women, from 
maturity to senescence (adapted from Pincus^s). 
the published studies of Pincus and associates." These investigators demonstrated 
that by the time of menopause, total urinary estrogen levels were no greater than 
those found in the urine of men of comparable age. The great difference between 
the sexes in the fourth to sixth decades of life was the progressive rise in the estriol 
fraction of male urine. Based on this observation, the authors suggested that age 
effects the metabolic conversion of estrogens differently in the two sexes. 
These data concerning estrogen excretion by women 20 to 40 years postmeno-
pausal have been confirmed by others, but whether such estrogens are the products 
of the postmenopausal ovary is open to question. Wotiz and associates^ " have 
reported the in vitro conversion of C^-labeled testosterone to estrone, estriol and, 
to a lesser extent, estradiol by tissue obtained from the ovary of a woman 20 years 
postmenopausal. The stroma of this ovary was described as being hyperplastic. Such 
evidence might be considered to support the theory of Sommers '^ that stromal 
hyperplasia in postmenopausal women represents a functioning tissue, the presence 
of which can be correlated with the occurrence of breast carcinoma. On the other 
hand, West and co-workers^' have demonstrated in castrated, adrenalectomized women 
the conversion of testosterone to estrogens, a process presumably occurring in the 
liver. Paulsen and associates'^  administered hog FSH to six intact, postmenopausal 
women and found in two an increased excretion of urinary estrogens, measured by 
biological assay. These authors observed that the level of urinary estrogens of 
intact postmenopausal women were about twice that of contemporary castrates. 
McBride" of Scotland reported in 1957 that the quantity of the three major estrogens 
in urine of women averaging 10 years postmenopause was comparable to that of 
women at the low point in the menstrual cycle. No cyclic variation was noted 
in the former group, and the level of estrogen was unrelated to the histologic pattern 
of the endometrium. Furthermore, bilateral oophorectomy in postmenopausal women 
led to no reduction in levels of urinary estrogens. 
335 
Smith and Mellinger 
Gynecologists and internists long have recognized clinical evidence that great 
differences exist in levels of ovarian function in postmenopausal women. Clinical 
data concerning this point (Table I I ) were recently collected by the authors. Levels 
Table I I 
Estrogen Effects on Vaginal Epithelia 
Clinical No. Cytologic Rating* 
Categories Subjects 
A B C D 
Normals 58 12.0 44.8 32.8 10.4 
Osteoporosis 27 .1.7 17.8 55.6 22.9 
Breast Cancer 58 0.0 31.0 34.5 34.5 
*Per cent distribution, adjusted for time after menopause 
A=cornified and noncornified superficial cells 
D=basal and parabasal cells 
B and C=intermediate groups 
of estrogen effect were judged by the degree of maturity of the vaginal epithelium, 
and two groups of patients (breast cancer and osteoporosis) were compared to 
contemporary normal subjects who had been found free of any neoplasm at a 
large cancer detection clinic. While a relatively high percentage of all subjects 
maintain mature epithelia years after the menopause, differences of probable signifi-
cance were found between normals and the two patient groups. Whatever the 
source of estrogens in postmenopausal women it appears that they are of some 
biological importance to the host. An understanding of hormonal functions of the 
elderly is at least equal in importance to problems concerning reproduction and 
fertility, because these functions bear heavily on such complications of the aging 
process as osteoporosis, atherosclerosis and carcinoma. 
Progesterone has two important roles, as an intermediate in corticoid, androgen 
and estrogen biosynthesis, and as a hormone secretion itself. As a major intermediate 
in the biosynthesis of adrenocorticoids, progesterone normally undergoes a rapid 
hydroxylation at Ci? with only small amounts excreted in urine as the pregnanediol 
derivative. However, selective enzymatic deficiencies in the adrenal cortex may 
result in failure of hydroxylation at C21, as in the syndrome of congenital adrenal 
virilism. Under these conditions of impaired Cortisol synthesis and compensatorily 
increased ACTH release, the accelerated adrenal steroidogenesis produces 17-hy-
droxyprogesterone in large amounts. This latter compound is reduced and excreted 
as pregnanetriol in urine, one of the biochemical hallmarks of the adrenogenital 
syndrome. 
Progesterone is considered phylogenetically to have become significant in re-
productive physiology when ovoparity was superseded by viviparity in the animal 
kingdom." Its metabolism to pregnanediol, the major excretion product in urine, 
involves a series of reduction steps. The four pregnanediol isomers represent only 
one group of the several urinary metabolites that have been identified. Pregnanediol, 
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excreted as a glucuronide conjugate, can be recovered in the urine during the luteal 
phase of the menstrual cycle in amounts of approximately 2 to 4 mg, daily. 
Many of the concepts concerning mechanisms of steroid synthesis in ovary and 
testis have been derived to a great extent from in vitro studies of human tumor 
tissue. The hazard of error is great in assuming that knowledge of hormone bio-
synthesis by tumors can be applied fully to function of the normal human gonad. 
Competent pathologists and endocrine histologists admit the difficulties of distinguishing, 
for instance, luteomas from Leydig cell tumors, and these from certain adrenocortical 
tumors arising from adrenal rests in the gonad. There have been reports'' in recent 
years of gonadal tumors synthesizing steroids hydroxylated at the Cn position, which 
might suggest that the gonads normally contain an 11-/3 hydroxylating enzyme, as 
does the adrenal cortex for the biosynthesis of the glucocorticoids. There is yet no 
evidence for this in the normal gland, however. The critical issue in such studies 
of gonadal tumors is which method, the histological or biochemical, will be accepted 
as the final determinant of whether the tumor was derived from gonadal or displaced 
adrenal tissue. 
As to the human in vivo studies most data have been derived chiefly from 
analyses of excretory products. Until more is known of metabolic pathways, blood 
concentrations, gonadal blood flow and the renal handling of steroids and their 
metabolites, it will be difficult to describe with any precision the steroid productivity 
of the gonads. 
In addition to the gonadal steroids there is one non-steroid hormone of the 
ovary, relaxin, which can be given passing recognition. This substance has been 
demonstrated only during pregnancy, and apparently is of both ovarian and placental 
origin. Hisaw" in 1929 first isolated relaxin from corpus luteum extracts and 
defined its action in the softening and relaxation of pelvic ligaments of parturient 
rodents. The results of several clinical studies concerning the efficacy of relaxin 
in the treatment of premature labor'"-" have been conflicting. 
HORMONAL INTERRELATIONSHIPS 
The gonads have long been viewed as victims of thyroidal and adrenal dysfunction, 
yet much of the accusation has been based on highly circumstantial clinical evidence, 
particularly in respect to the thyroid. Despite the almost overwhelming clinical 
testimony, fortunately not all published, regarding the therapeutic elTicacy of desic-
cated thyroid in disturbances of gonadal function, there have been few scientific 
demonstrations of an intimate interrelationship. It has been claimed that patients 
with untreated myxedema have prominent ovarian cysts, and Janes'"" reported a 
high incidence of cystic ovaries in rats with long-standing induced hypothyroidism. 
Meites'" has shown that such animals are more responsive to chorionic gonadotropin, 
which seems to exhibit more FSH-Iike action in the hypothyroid animal than in the 
euthyroid. Beierwaltes"' found normal amounts of gonadotropins in the urine of 
myxedematous women, an observation confirmed in our laboratory in the assay of 
urine from postmenopausal women with spontaneous myxedema. Goldsmith and 
associates'" have studied the menstrual pattern of women with disturbed thyroid 
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function. In 70 per cent of patients with hyperthyroidism, ovulation occurred regularly, 
yet practically all had a marked degree of oligomenorrhea. Seven of ten premenopausal 
females with myxedema demonstrated ovulatory failure, while two had normal 
ovulation and menses. All were restored to normal menstrual cycles after proper 
treatment with desiccated thyroid. The investigators considered the menstrual defects 
to be the result of inadequate production or effectiveness of the luteinizing hormone. 
The evidence that the level of basal metabohc rate determines to a great 
extent the rate of estrogen disposal is quite consistent with the frequently encountered 
clinical observation of altered menstrual patterns in women with thyroid dysfunction. 
The known acceleration of rates of estrogen conjugation and excretion in a thyroxin-
induced hypermetabolic environment may acount for the hypo- and oligomenorrhea 
characteristic of the hyperthyroid female. Contrariwise, delayed metabolism of 
estrogen in experimentally produced hypothyroidism is consistent with the menorrhagia 
which often occurs in patients with myxedema. This important hormonal relationship 
is probably liver dependent, since this organ is the major site of estrogen metabolism. 
There is less evidence of significance relative to the effects of thyroxin on androgen 
metabolism. However, in 1956 Bradlow and associates" reported high urinary etio-
cholanolone to androsterone ratios in myxedema patients, and a partial correction 
toward normal when triiodothyronine was administered. 
There is evidence that estrogens in turn can modify certain aspects of thyroid 
function, although the biological significance of this relationship has not been defined. 
The best example is the known action of estrogens to increase the concentration 
of circulating protein-bound iodine. The demonstration of increased thyroxin-binding 
protein, both in pregnancy and in estrogen-treated women, seems to explain the 
phenomenon since the high PBI concentrations are unassociated with evidence of 
an increased metabolic action of the circulating thyroxin. That the effect is dependent 
on several factors is suggested by the studies of Stoddard and associates'" who 
reported no consistent change in concentrations of serum precipitable iodine after 
bilateral oophorectomy of women in their reproductive years, and of Engbring and 
co-workers'" who have shown that the thyroid gland is not necessary for the estrogen-
induced rise in PBI concentration. They concluded from their studies that the 
increased PBI is due to a prolongation of the thyroxine survival time. Thus, the 
sequence of action can be outlined as follows: 1) increased thyroxine-binding capacity 
of serum; 2) increased concentration of PBI; 3) decreased utilization of thyroid 
hormone; 4) decreased BMR; 5) increased pituitary secretion of TSH; 6) increased 
thyroid gland activity. Testosterone, on the other hand, appears to lower serum 
PBI levels, but the mechanism has not been defined. 
Clinicians have postulated that the cycles of follicular and luteal activity in 
the normal female, by virtue of sequential stimulation and suppression of hypophyseal 
function, including TSH release, result in cyclic variations in thyroid function and 
ultimately in goiter, nodular or otherwise. Experimental support of this concept in 
man is lacking, however. Reineke and Soliman"' have reviewed evidence for a 
functional interrelationship of thyroid and gonad in animals and demonstrated that 
at estrus the metabolic rate is often maximal and, by the criterion of thyroidal uptake 
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of r " , that thyroid function is also maximal. In ovariectomized rats, the administration 
of small doses of estrogen results in an increased P" uptake by the thyroid. 
Existence of a complex interrelationship between the gonad and adrenal may 
be anticipated by virtue of the common embryologic origin of these glands. Clinical 
endocrinologists in the past three or four years, recognizing the potential significance 
to the ovary of adrenal function, normal and abnormal, have successfully used the 
glucocorticoids in the treatment of ovarian dysfunction and infertility'"''"'™. 
That an ovarian-adrenal relationship exists in the normal female is evident in 
the conspicuous change in adrenocortical function which occurs in the years just 
before and during menarche. The data shown in Figure 13 have been taken from 
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Figure 13 
Urinary 17-ketosteroid excretion from childhood to adolescence. 
Summation of data from Nathanson^ i and Oesting." 
the well-known studies of Nathanson and associates,and Oesting and Webster." 
The rise in urinary 17-ketosteroids from prepubertal levels of one or two milligrams 
to adult levels of 14 or 16 milligrams represents an impressive alteration in adrenal 
function brought on as a result of, or at least simultaneously with, the rise in ovarian 
function. Evidence that these ketosteroids are adrenal and not ovarian in origin has 
been previously cited. Reifenstein et al.=' once postulated that pituitary LH, released 
in increasing amounts from the pituitary through the effects of estrogens from the 
maturing ovary, resulted in the so-called adrenarche. This concept has never been 
substantiated. Furthermore, recent evidence is available to indicate that chorionic 
gonadotropin, possessing L H action, does not stimulate the adrenal cortex, judged 
by levels of urinary 17-ketosteroids and 17-hydroxycorticoids." Patients with primary 
hypogonadotropic hypogonadism and those with gonadal dysgenesis have been found 
to excrete low levels of urinary 17-ketosteroids despite normal rates of glucocorticoid 
biosynthesis."'" 
Recently, several groups of investigators have shown an effect of estrogens on 
one interesting aspect of adrenal function.'''" Administration of stilbesterol or ethinyl 
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estradiol in moderate amounts to a normal person results in materially increased 
levels in plasma of free 17-hydroxycorticoids. This phenomenon has been shown 
to result from a decreased rate of corticosteroid reduction in liver and to an increased 
plasma binding of Cortisol. However, in contrast to the increasing levels of urinary 
17-ketosteroids observed during gonadal activation at puberty, the opposite effect 
has been observed during estrogen administration. In Table I I I are data from our 
Table I I I 
Effect of Oral Estrogen in Nine Virilized Women. 
Treatment 
(No. of assays) 
17-KS 
mg./24 hr. 
mean ± S.E. P value 
None (22) 18.2 ± 1.7 — 
Estrogen (26) 12.7 ± 1.7 0.05 — 0.02 
recent studies of a group of virilized women. In these subjects, 17-ketosteroid 
excretion was observed to fall from 18.2 to 12.7 mg. during the ingestion of 
Estinyl.® Hermann and associates'' have also observed reduced urinary 17-ketosteroids 
during periods of estrogen administration. By fractionation analyses of the 17-keto-
steroids, they found the decreased excretion to involve steroids of both adrenal and 
gonadal origin. Furthermore, this phenomenon occurred in their study at physiologic 
levels of administered estrogen. 
In addition to suppressing gonadal steroidogenesis via inhibition of gonadotropin 
release, administered estrogens could also lower urinary 17-ketosteroids by: 1) in-
hibiting the conversion of corticoids to 17-ketosteroids; 2) suppressing adrenal androgen 
secretion through ACTH inhibition, via elevated titers of plasma Cortisol; and 3) 
the increased plasma binding or altered metabolism of the androgen precursors 
themselves. Since estrogen administration can reduce the urinary 17-ketosteroid 
response to infused ACTH without altering the plasma Cortisol response, Hermann 
and associates'" concluded that estrogens increase the plasma binding of 17-ketosteroid 
precursors. 
In several species, under both natural and experimental conditions, adrenal 
hyperplasia has been induced by the administration of estrogens."-" This effect is 
ACTH dependent, and Witschi" has postulated from his experiments that in the 
amphibia at least, the hypothalamic-hypophyseal release mechanism, essential to 
ovulation, is dependent not only on the gonadotropic but also on the adrenotropic 
system. The postulated mechanism of ovulation is depicted in Figure 14. Whether 
or not this observation applies to human females is problematical, but the presently 
inexplicable successes reported to follow glucocorticoid administration to infertile, 
non-virilized women may involve some such system. 
Concerning the effect of the glucocorticoids on gonadal function, it might be 
reasoned on ontogenetic ground that a condition of relative permissiveness exists, 
since complex gonadal functions evolved under the influence of a much older ad-
renocortical system. That is, within physiological limits, changing adrenal function 
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Figure 14 
Endocrine interrelationships during ovulation in the amphibia. The postulated role of the 
adrenotropic system is based on the observations of Witschi." 
has only a minor effect on gonadal function. Clinical experience with patients having 
adrenocortical insufficiency provides support for this concept, since undisturbed 
gonadal function is often observed in patients with Addison's disease. In instances 
of complete adrenocortical insufficiency, amenorrhea in women and impotence in 
men may result, but the mechanism would seem to be an adaptation for survival 
rather than a reflection of endocrine dependency. Continued ovulation and, indeed, 
fertility with resulting pregnancy were not rare experiences for the Addisonian female 
treated in the pre-cortisone era with sodium chloride and deoxycorticosterone. Con-
tinuation of pregnancy under these conditions may have been dependent to a great 
extent on placental synthesis of glucocorticoids, although results in recent studies 
do not support this idea." 
Physicians have had a rich opportunity to observe the effects of increased 
glucocorticoid levels on gonadal function as a result of the widespread use of 
corticoids in clinical practice. Interference with function does occur, but is usually 
observed quite late in the course of treatment, at least if conventional dosages are 
used. Irregular menses, amenorrhea and reduced potency result, but they are not 
common in otherwise healthy persons. With high dose glucocorticoid therapy 
particularly for persons with systemic disease, the aforementioned effects are likely 
to occur earlier. The beneficial results of glucocorticoid therapy in women with 
ovarian dysfunction are considered due to improvement of pre-existing endocrine 
abnormalities. 
One action by which adrenal steroids could alter hypophyseal-gonadal function 
was first reported by Sohval," and independently by Smith" in 1950. Markedly 
increased levels of gonadotropins were observed in urine of patients receiving glu-
cocorticoid or corticotropin therapy. The patients under study were in the initial 
phases of treatment with conventional but physiologically abnormal doses of the 
hormones. Gonadotropin titers were increased two to six fold in both studies. The 
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mechanism remains unknown but increased renal clearance of the gonadotropin as 
a result of the corticoid effect on kidney function is considered one explanation. 
Whatever the basis, disturbed gonadal function manifested as amenorrhea and oligo-
menorrhea with anovulatory cycles, might be the anticipated result if the corticoid 
effect on gonadotropin release were prolonged. Study of patients with Cushing's 
syndrome provides conflicting evidence, since low or absent gonadotropin excretion 
has been observed." These low titers may reflect the general protein depletion of 
prolonged hypercorticism, with curtailment of gonadotropin formation such as occurs 
in starvation. Although increased renal loss of gonadotropin may have occurred in 
the early phases of the hypercorticism, there is no supporting data for this thesis. 
However, lannaccone and associates" observed that ovaries of premenopausal Cushing's 
patients were small and white, with diminished follicular activity. Primordial follicles 
were sharply reduced and the overall picture was that of premature aging. These 
observers cited no gonadotropin data, stating that "disordered pituitary gonadotropic 
function cannot be excluded as a possible contributory cause". It seems likely that 
depleted gonadotropin secretion could have been a very important factor even though 
the ovaries histologically were not much different from those seen in postmenopausal 
women with high gonadotropin output. 
This essay, keyed to the clinically oriented reader, is an attempt to integrate 
established knowledge with certain of the recent contributions in the study of 
gonadal development and function, particularly as it relates to man. Without question, 
some areas of the broad subject have been insufficiently discussed, and of the many 
available references, only a few have been cited. For more extensive information, 
the reader may turn to several monographs and texts recently published."'™" Just 
as in the case of insulin, therapeutic triumphs in clinical endocrinology are often 
achieved before the modus operandi are known. Yet the past ten years of accumulating 
insight regarding adrenal pathophysiology and biochemistry have prepared the way 
for gaining the more elusive knowledge concerning the gonads. A broad conceptual 
framework of gonadal form and function is helpful for understanding the contributions 
to come. The present review may serve this purpose for those not intimately con-
cerned with endocrine research. 
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